Your browser doesn't support javascript.
loading
An open-label, randomized and multi-center clinical trial to evaluate the efficacy of Silibinin in preventing drug-induced liver injury.
Gu, Jin; Tang, Shen-Jie; Tan, Shou-Yong; Wu, Qi; Zhang, Xia; Liu, Cun-Xu; Gao, Xu-Sheng; Yuan, Bao-Dong; Han, Li-Jun; Gao, Ai-Ping; Wu, Mei-Ying; Huang, Li-Hua; Ma, Jun; Xiao, He-Ping.
Affiliation
  • Gu J; Clinic and Research Center of Tuberculosis, Shanghai Key Lab of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine China.
  • Tang SJ; Beijing Chest Hospital, Capital Medical University China.
  • Tan SY; Guangzhou Chest Hospital China.
  • Wu Q; Tianjin Haihe Hospital China.
  • Zhang X; Nanjing Chest Hospital China.
  • Liu CX; Guangxi Longtan Hospital China.
  • Gao XS; Shandong Provincial Chest Hospital China.
  • Yuan BD; Tuberculosis Institute of Wuhan City China.
  • Han LJ; Infectious Disease Hospital of Changchun City China.
  • Gao AP; Anhui Chest Hospital China.
  • Wu MY; The Fifth People's Hospital of Suzhou China.
  • Huang LH; Wuxi Infectious Disease Hospital China.
  • Ma J; Tianjin Medical University China.
  • Xiao HP; Clinic and Research Center of Tuberculosis, Shanghai Key Lab of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine China.
Int J Clin Exp Med ; 8(3): 4320-7, 2015.
Article in En | MEDLINE | ID: mdl-26064348
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Int J Clin Exp Med Year: 2015 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Int J Clin Exp Med Year: 2015 Type: Article